维普中文期刊产品整合服务
16篇 您的检索式:作者名="Kalinowski DS"
    题名 作者 年代 出处 被引量
1Cancer cell i ron metabolism and the development of potent iron chelators as anti-tumour agents显示文摘Richardson DR Kalinowski DS Lau S 2009Biochimic Biophysica Acta2009,1790,7:1
2Design, synthesis and charaeterization of new iron chela tors with anti proliferative activity: structure-activity relationships of novel thiohydrazone analogs显示文摘Kalinowski DS Sharpe PC Bernhardt PV 2007Journal of Medicinal Chemistry2007,50,24:1
3Cancer cell iron metabolism and the development of potent chelators as antitumour agents显示文摘Richardson DR Kalinowski DS Lau S 2009Biochim Biophys Acta2009,1790,:1
4Design, synthesis, and characterization of novel iron chelators: structure-activity relation- ships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoylanalogues as potent antitumor agents 显示文摘Kalinowski DS Yu Y Sharpe PC 2007J Med Chem2007,50,15:1
5Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy 显示文摘Fang BA Park KC Kalinowski DS 2014Biochim Biophys Acta2014,1845,1:1
6The evolution of iron chelators for the treatment of iron overload disease and cancer显示文摘Kalinowski DS Richardson DR 2005Pharmacol Rev2005,57,4:1
7Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents显示文摘Richardson DR Kalinowski DS Lau S 2009Bioehim Biophys Acta2009,1790,7:1
8The evolution of iron chelators for the treatment of iron overload disease and cancer 显示文摘Kalinowski DS Richardson DR 2005Phar- macol Rev2005,57,4:1
9Thiosemicarbazones from the old to new: iron chelators that are more than just ribonu- eleotide reductase inhibitors显示文摘Yu Y Kalinowski DS Kovacevic Z 2009J Med Chem2009,52,17:1
10Protection against hy- drogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibro- blasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class 显示文摘Lim CK Kalinowski DS Richardson DR 2008Mol Pharmacol2008,74,1:1
11Design, synthesis, and characterization of novel iron chelators : structure activity relation- ships of the 2-benzoylpyrldine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents 显示文摘Kalinowski DS Yu Y Sharpe PC 2007J Med Chem2007,50,15:1
12Protection agalnst hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class 显示文摘LIM CK KALINOWSKI DS RICHARDSON DR 2008Mol Pharmacol2008,74,1:1
13Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents 显示文摘RICHARDSON DR KALINOWSKI DS LAU S 2009Biochim Biophys Acta2009,1790,7:1
14Iron chelators: development of novel compounds with high and selective anti-turnout activity 显示文摘KOVACEVIC Z KALINOWSKI DS LOVE JOY DB 2010Curt Drug Deliv2010,7,3:1
15The evolution of iron chelators for the treatment of iron overload disease and cancer显示文摘Kalinowski DS Richardson DR 2005Pharmacol Rev2005,57,:1
16The evolution of iron chelators for the treatment of iron overload disease and cancer 显示文摘Kalinowski DS Richardson DR 2005Pharmacol Rev2005,57,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费